Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Biotechnology

Healthcare
$1.43 -2.40%

-$0.04 today

Market cap
$82.18M
Beta
3.23
P/E (TTM)
-2.2
EPS (TTM)
-$0.75
52W Low $1.62High $4.94

Volume 0.60M

Average 1.31M

BDTX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Black Diamond Therapeutics, Inc.NASDAQ: BDTX

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 57.23M shares rose 1.0% year over year, in line with the +1.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +16.2% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.0% toward the trailing-twelve-month pace of +1.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.23M+0.2% QoQ
Last fiscal yearDec 2025
56.87M+3.3% YoY
LTMMar 2026
56.95M+1.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year+3.3%——
3-year CAGR+16.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
56.87M USD
Year-over-year change
+3.3%
4-year CAGR
+12.0%

Weighted Avg Shares vs competitors

How BDTX compares with its peers on the latest reported figures

  • BDTX's LTM Mar 2026 weighted avg shares of 56.95M shares is the 5th highest of the 11 companies compared; the peer median is 47.5M shares.
  • Its year-over-year change of +1.3% is the 9th highest of 11, against a peer median of +15.6%.
  • Over three fiscal years its annual growth of +16.2% compares with a peer median of +17.0%.
BDTX Competitors Peer median
Weighted Avg Shares for BDTX and competitors
Company Period LTM YoY 3-year CAGR
IVAInventiva S.A.FY2025186.8M +259.4%+65.2%
TNYATenaya Therapeutics, Inc.LTM Mar 2026158.02M +71.7%+50.6%
CRBUCaribou Biosciences, Inc.LTM Mar 202694.18M +3.6%+15.4%
FHTXFoghorn Therapeutics Inc.LTM Mar 202664.63M +7.9%+14.8%
BDTXBlack Diamond Therapeutics, Inc.LTM Mar 202656.95M +1.3%+16.2%
ABEOAbeona Therapeutics Inc.LTM Mar 202654.09M +20.9%+88.9%
IMRXImmuneering CorporationLTM Mar 202640.92M +29.8%+18.6%
FENCFennec Pharmaceuticals Inc.LTM Mar 202630.27M +10.4%+2.8%
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 202621.77M +1.1%+0.7%
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 202621.37M +0.6%+1.2%
AVTXAvalo Therapeutics, Inc.LTM Mar 202615.86M +130.2%+599.3%
Peer median (excluding BDTX) 47.5M+15.6%+17.0%

Competitors are the stored peer set for BDTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000070M
Cost of Revenue00437K0325K
Gross Profit00(437K)069.68M
Gross Margin————99.5%
Research & Development96.83M64.44M58.91M51.31M33.56M
Selling, General & Admin30.04M28.39M27.11M27.47M16.57M
Operating Expenses126.87M92.83M86.02M78.78M49.81M
Depreciation & Amortization205K508K437K343K325K
EBITDA(125.39M)(90.66M)(82.01M)(69.33M)22.69M
EBITDA Margin————32.4%
Operating Income(126.87M)(92.83M)(86.46M)(78.78M)19.87M
Operating Margin————28.4%
Interest Income3.46M2.03M1.92M2.18M4.06M
Interest Expense00000
Other Income / Expenses1.28M1.66M4.02M9.11M2.5M
Income Before Tax(125.6M)(91.17M)(82.44M)(69.68M)22.37M
Pre-Tax Margin————32.0%
Income Tax Expense00000
Net Income(125.6M)(91.17M)(82.44M)(69.68M)22.37M
Net Margin————32.0%
EPS (Basic)(3.47)(2.52)(1.88)(1.27)0.39
EPS (Diluted)(3.47)(2.52)(1.88)(1.27)0.39
Weighted Avg Shares36.19M36.23M43.95M55.03M56.87M
Weighted Avg Shares (Diluted)36.19M36.23M43.95M55.03M57.56M

Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Intrinsic Alpha fair value

Locked

Current Price

$1.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.